$DVAX
DYNAVAX TECHNOLOGIES CORP

2021 Q4 Form 10-Q Financial Statement

#000095017021003113 Filed on November 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $195.1M $108.3M $13.41M
YoY Change 897.8% 707.14% 26.85%
Cost Of Revenue $74.01M $60.09M $4.030M
YoY Change 1722.96% 1391.07% -34.47%
Gross Profit $121.1M $48.18M $9.380M
YoY Change 681.52% 413.65% 111.74%
Gross Profit Margin 62.06% 44.5% 69.93%
Selling, General & Admin $28.80M $26.93M $21.54M
YoY Change 63.82% 25.02% 16.68%
% of Gross Profit 23.79% 55.89% 229.62%
Research & Development $11.12M $6.186M $8.521M
YoY Change 16.41% -27.4% -32.69%
% of Gross Profit 9.18% 12.84% 90.84%
Depreciation & Amortization $1.016M $1.078M $1.110M
YoY Change -7.64% -2.88% -84.05%
% of Gross Profit 0.84% 2.24% 11.83%
Operating Expenses $39.92M $33.11M $30.06M
YoY Change 47.13% 10.16% -3.41%
Operating Profit $81.14M $16.07M -$13.83M
YoY Change -797.1% -216.22% -54.86%
Interest Expense $17.55M $1.676M $4.794M
YoY Change -464.84% -65.04% 0.31%
% of Operating Profit 21.63% 10.43%
Other Income/Expense, Net $2.321M $238.0K -$420.0K
YoY Change 87.18% -156.67% -350.0%
Pretax Income $100.6M -$28.43M $4.400M
YoY Change -750.21% -746.14% -113.15%
Income Tax $808.0K $0.00
% Of Pretax Income 0.8%
Net Earnings $99.78M -$28.43M $4.401M
YoY Change -744.98% -745.99% -113.15%
Net Earnings / Revenue 51.15% -26.26% 32.81%
Basic Earnings Per Share -$0.24 $0.04
Diluted Earnings Per Share $529.6K -$0.24 -$0.15
COMMON SHARES
Basic Shares Outstanding 120.0M 116.9M 109.8M
Diluted Shares Outstanding 116.9M 112.0M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $546.0M $414.2M $177.2M
YoY Change 230.81% 133.72% 1.32%
Cash & Equivalents $436.2M $246.4M $32.69M
Short-Term Investments $109.8M $167.8M $144.5M
Other Short-Term Assets $233.4M $170.9M $18.80M
YoY Change 504.71% 808.81% 229.82%
Inventory $61.34M $67.30M $59.03M
Prepaid Expenses
Receivables $116.2M $200.4M $35.00M
Other Receivables $15.60M $0.00 $0.00
Total Short-Term Assets $972.5M $852.7M $290.0M
YoY Change 235.33% 194.02% 26.75%
LONG-TERM ASSETS
Property, Plant & Equipment $35.02M $34.25M $57.70M
YoY Change 14.57% -40.64% -5.72%
Goodwill $2.125M $2.171M
YoY Change -7.49%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.398M $3.623M $3.500M
YoY Change -4.9% 3.51% -14.63%
Total Long-Term Assets $66.73M $67.04M $63.40M
YoY Change 5.48% 5.74% -12.19%
TOTAL ASSETS
Total Short-Term Assets $972.5M $852.7M $290.0M
Total Long-Term Assets $66.73M $67.04M $63.40M
Total Assets $1.039B $919.7M $353.4M
YoY Change 194.18% 160.25% 17.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.600M $3.596M $5.300M
YoY Change -21.5% -32.15% -31.17%
Accrued Expenses $49.80M $87.91M $23.30M
YoY Change 160.73% 277.3% -4.12%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $556.4M $528.9M $66.60M
YoY Change 618.76% 694.2% 43.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $220.2M $179.7M
YoY Change -100.0% 22.55% 1.18%
Other Long-Term Liabilities $5.664M $79.00K $37.80M
YoY Change 120.56% -99.79% -0.26%
Total Long-Term Liabilities $5.664M $79.00K $217.5M
YoY Change -96.89% -99.96% 0.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $556.4M $528.9M $66.60M
Total Long-Term Liabilities $5.664M $79.00K $217.5M
Total Liabilities $816.9M $852.1M $284.1M
YoY Change 177.3% 199.94% 8.48%
SHAREHOLDERS EQUITY
Retained Earnings -$1.217B -$1.317B
YoY Change -5.93%
Common Stock $1.442B $1.386B
YoY Change 6.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $222.4M $67.58M $69.28M
YoY Change
Total Liabilities & Shareholders Equity $1.039B $919.7M $353.4M
YoY Change 194.18% 160.25% 17.4%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $99.78M -$28.43M $4.401M
YoY Change -744.98% -745.99% -113.15%
Depreciation, Depletion And Amortization $1.016M $1.078M $1.110M
YoY Change -7.64% -2.88% -84.05%
Cash From Operating Activities $120.5M $66.21M -$27.82M
YoY Change -865.55% -338.0% 26.57%
INVESTING ACTIVITIES
Capital Expenditures -$3.036M -$3.629M -$260.0K
YoY Change 294.29% 1295.77% -97.17%
Acquisitions
YoY Change
Other Investing Activities $57.97M $49.30M -$1.790M
YoY Change 283.68% -2854.25% -94.23%
Cash From Investing Activities $54.94M $45.67M -$2.050M
YoY Change 283.11% -2327.9% -94.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.82M 5.322M 1.410M
YoY Change 21065.71% 277.45% -97.86%
NET CHANGE
Cash From Operating Activities 120.5M 66.21M -27.82M
Cash From Investing Activities 54.94M 45.67M -2.050M
Cash From Financing Activities 14.82M 5.322M 1.410M
Net Change In Cash 190.3M 117.2M -28.46M
YoY Change -14404.59% -511.82% -903.95%
FREE CASH FLOW
Cash From Operating Activities $120.5M $66.21M -$27.82M
Capital Expenditures -$3.036M -$3.629M -$260.0K
Free Cash Flow $123.5M $69.84M -$27.56M
YoY Change -925.2% -353.41% 115.48%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001029142
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-34207
dei Entity Registrant Name
EntityRegistrantName
Dynavax Technologies Corp
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0728374
dei Entity Address Address Line1
EntityAddressAddressLine1
2100 Powell Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 900
dei Entity Address City Or Town
EntityAddressCityOrTown
Emeryville
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94608
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
848-5100
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
DVAX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
119952132
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
246351000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32073000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
167804000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
132963000
CY2021Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
200362000
CY2020Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
22661000
CY2021Q3 us-gaap Inventory Net
InventoryNet
67297000
CY2020Q4 us-gaap Inventory Net
InventoryNet
63689000
CY2021Q3 dvax Prepaid Manufacturing
PrepaidManufacturing
109763000
CY2020Q4 dvax Prepaid Manufacturing
PrepaidManufacturing
29423000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
61093000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9206000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
852670000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
290015000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34251000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30567000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26772000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26583000
CY2021Q3 us-gaap Goodwill
Goodwill
2171000
CY2020Q4 us-gaap Goodwill
Goodwill
2297000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
224000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
237000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3623000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3573000
CY2021Q3 us-gaap Assets
Assets
919711000
CY2020Q4 us-gaap Assets
Assets
353272000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3596000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3312000
CY2021Q3 dvax Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
3935000
CY2020Q4 dvax Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
2805000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
87910000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19099000
CY2021Q3 dvax Warrant Liability Current
WarrantLiabilityCurrent
72017000
CY2020Q4 dvax Warrant Liability Current
WarrantLiabilityCurrent
10736000
CY2021Q3 us-gaap Deferred Revenue
DeferredRevenue
358588000
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
38212000
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2889000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3247000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
528935000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
77411000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1094000
CY2021Q3 dvax Long Term Debt Noncurrent1
LongTermDebtNoncurrent1
0
CY2020Q4 dvax Long Term Debt Noncurrent1
LongTermDebtNoncurrent1
179811000
CY2021Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
220223000
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0
CY2021Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
67969000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34929000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34789000
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
79000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2568000
CY2021Q3 us-gaap Liabilities
Liabilities
852135000
CY2020Q4 us-gaap Liabilities
Liabilities
294579000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
278000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
278000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
119787000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119787000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110190000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
110190000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
120000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
110000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1386114000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
919711000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1352374000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1528000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
273000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1317130000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1294064000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
67576000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
58693000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
353272000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108270000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13414000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
244372000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27001000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6186000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8521000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21111000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19058000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26926000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21538000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70932000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
61418000
CY2021Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
CY2020Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
6851000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
6851000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
92202000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
27239000
us-gaap Costs And Expenses
CostsAndExpenses
190603000
us-gaap Costs And Expenses
CostsAndExpenses
83477000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
16068000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13825000
us-gaap Operating Income Loss
OperatingIncomeLoss
53769000
us-gaap Operating Income Loss
OperatingIncomeLoss
-56476000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
39000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
269000
us-gaap Investment Income Interest
InvestmentIncomeInterest
134000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1190000
CY2021Q3 us-gaap Interest Expense
InterestExpense
1676000
CY2020Q3 us-gaap Interest Expense
InterestExpense
4794000
us-gaap Interest Expense
InterestExpense
9497000
us-gaap Interest Expense
InterestExpense
14257000
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
2022000
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
1926000
us-gaap Sublease Income
SubleaseIncome
5714000
us-gaap Sublease Income
SubleaseIncome
5779000
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
45121000
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-21245000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
68576000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4200000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
238000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-420000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111973000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114540000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
622000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-209000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28430000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
4401000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
us-gaap Net Income Loss
NetIncomeLoss
-59773000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116903000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109816000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114540000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97589000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116903000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98577000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28430000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
4401000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
us-gaap Net Income Loss
NetIncomeLoss
-59773000
CY2021Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0
CY2020Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
108000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
21000
CY2021Q3 dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
-18000
CY2020Q3 dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
-75000
dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
11000
dvax Change In Unrealized Gain On Marketable Securities Available For Sale
ChangeInUnrealizedGainOnMarketableSecuritiesAvailableForSale
30000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-797000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1256000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1812000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1356000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-815000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1073000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1801000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1365000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-29245000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5474000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24867000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58408000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
83380000
CY2021Q3 dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
3982000
CY2021Q3 dvax Stock Issued Exercise Of Warrants During Period Value New Issues
StockIssuedExerciseOfWarrantsDuringPeriodValueNewIssues
3625000
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
458000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5376000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-815000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28430000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
67576000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
58693000
dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
5317000
dvax Stock Issued Exercise Of Warrants During Period Value New Issues
StockIssuedExerciseOfWarrantsDuringPeriodValueNewIssues
11553000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
841000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
28156000
dvax Adjustments To Additional Paid In Capital Capped Call Options
AdjustmentsToAdditionalPaidInCapitalCappedCallOptions
-27240000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15123000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1801000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
67576000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58295000
CY2020Q3 dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
213000
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
361000
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
839000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4102000
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1073000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
4401000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
69284000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
8290000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
dvax Issuance Withholding Of Common Stock Upon Exercise Of Options Vesting Of Restricted Stock Units And Vesting Of Early Exercised Options Net Value
IssuanceWithholdingOfCommonStockUponExerciseOfOptionsVestingOfRestrictedStockUnitsAndVestingOfEarlyExercisedOptionsNetValue
224000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
672000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
108537000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9968000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1365000
us-gaap Net Income Loss
NetIncomeLoss
-59773000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
69284000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
us-gaap Net Income Loss
NetIncomeLoss
-59773000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3280000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3166000
dvax Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
2013000
dvax Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1906000
dvax Gain On Disposal Of Property And Equipment And Lease Termination
GainOnDisposalOfPropertyAndEquipmentAndLeaseTermination
0
dvax Gain On Disposal Of Property And Equipment And Lease Termination
GainOnDisposalOfPropertyAndEquipmentAndLeaseTermination
76000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-442000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-193000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
0
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
56000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-106000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11406000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
50000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5232000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
68576000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4200000
us-gaap Share Based Compensation
ShareBasedCompensation
15123000
us-gaap Share Based Compensation
ShareBasedCompensation
9968000
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
0
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
2500000
dvax Non Cash Interest Expense
NonCashInterestExpense
2546000
dvax Non Cash Interest Expense
NonCashInterestExpense
2129000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
0
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-908000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
1000000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
6851000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
177701000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
22137000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3608000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
17701000
dvax Increase Decrease In Prepaid Manufacturing
IncreaseDecreaseInPrepaidManufacturing
80340000
dvax Increase Decrease In Prepaid Manufacturing
IncreaseDecreaseInPrepaidManufacturing
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
51887000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-545000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1433000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
2416000
dvax Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
2131000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
320376000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
21712000
dvax Increase Decrease In Long Term Deferred Revenue
IncreaseDecreaseInLongTermDeferredRevenue
67969000
dvax Increase Decrease In Long Term Deferred Revenue
IncreaseDecreaseInLongTermDeferredRevenue
0
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
70087000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6668000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
215031000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-76508000
dvax Payments To Acquire Technology Licenses
PaymentsToAcquireTechnologyLicenses
7000000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
164927000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
171982000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
129655000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
117650000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
20902000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6441000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3303000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
2859000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40713000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40874000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28156000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
108537000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
219822000
dvax Payments For Purchase Of Capped Call Options
PaymentsForPurchaseOfCappedCallOptions
27240000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
190194000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
4258000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
5317000
dvax Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net
ProceedsFromExerciseOfStockOptionsAndRestrictedStockAwardsNet
224000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
841000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
672000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40960000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
109433000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1013000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
214265000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7186000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32310000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40100000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246575000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32914000
us-gaap Interest Paid Net
InterestPaidNet
6965000
us-gaap Interest Paid Net
InterestPaidNet
12149000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1561000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2468000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
364000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
414200000
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-05-15
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28400000
us-gaap Net Income Loss
NetIncomeLoss
-23100000
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.2729166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that may affect the amounts reported in the condensed consolidated financial statements and accompanying notes, including amounts of revenues and expenses during the reported periods. Management’s estimates are based on historical information available as of the date of the condensed consolidated financial statements and various other assumptions we believe are reasonable under the circumstances. On an ongoing basis, we evaluate our estimates, judgments and methodologies. Significant estimates and assumptions in the condensed consolidated financial statements include those related to revenue recognition; accounts receivable; useful lives of long-lived assets, impairment of long-lived assets, including goodwill; valuation procedures for right-of-use assets and operating lease liabilities; valuation of inventory; fair value of warrants; balance sheet classification of Convertible Notes; income taxes, including the valuation allowance for deferred tax assets; research and development expenses; contingencies and share-based compensation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ materially from these estimates under different assumptions or conditions and could be further impacted by the COVID-19 pandemic. Changes in estimates are reflected in reported results in the period in which they become known.</span></p>
CY2021Q3 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2021Q3 us-gaap Fair Value Equity Level2 To Level1 Transfers Amount
FairValueEquityLevel2ToLevel1TransfersAmount
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
246351000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32073000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32688000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39884000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
224000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
237000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
226000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
216000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
246575000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32310000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32914000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40100000
CY2021Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
414113000
CY2021Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
42000
CY2021Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
414155000
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
165005000
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
48000
CY2020Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
17000
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
165036000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
167762000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
167804000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
0
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
0
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
167762000
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
167804000
CY2021Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
0
CY2021Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2020Q3 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
100000
us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
100000
CY2020Q3 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
0
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
30332000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
25121000
CY2021Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9956000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30293000
us-gaap Operating Lease Payments
OperatingLeasePayments
5100000
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
27009000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8275000
CY2021Q3 us-gaap Inventory Net
InventoryNet
67297000
CY2020Q4 us-gaap Inventory Net
InventoryNet
63689000
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.101
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1535000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
1550000
us-gaap Operating Lease Expense
OperatingLeaseExpense
4665000
us-gaap Operating Lease Expense
OperatingLeaseExpense
4703000
us-gaap Operating Lease Payments
OperatingLeasePayments
5200000
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2889000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3247000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34929000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34789000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
37818000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
38036000
CY2021Q3 dvax Lessor Sublease Rentals Payments To Be Received Remainder Of Fiscal Year
LessorSubleaseRentalsPaymentsToBeReceivedRemainderOfFiscalYear
1324000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5945000
CY2021Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Thereafter
LessorSubleaseRentalsPaymentsToBeReceivedDueThereafter
33742000
CY2021Q3 dvax Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
34444000
CY2021Q3 dvax Lessor Sublease Rentals Payments To Be Received Due
LessorSubleaseRentalsPaymentsToBeReceivedDue
57479000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
59791000
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
21973000
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
37818000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1768000
CY2021Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Year Two
LessorSubleaseRentalsPaymentsToBeReceivedDueYearTwo
5357000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6186000
CY2021Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Year Three
LessorSubleaseRentalsPaymentsToBeReceivedDueYearThree
5518000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5652000
CY2021Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Year Four
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFour
5684000
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5796000
CY2021Q3 dvax Lessor Sublease Rentals Payments To Be Received Due Year Five
LessorSubleaseRentalsPaymentsToBeReceivedDueYearFive
5854000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.101
CY2021Q3 us-gaap Purchase Obligation
PurchaseObligation
149300000
CY2004Q4 us-gaap Pledged Assets Separately Reported Securities Pledged Under Letter Of Credit Facilities At Fair Value
PledgedAssetsSeparatelyReportedSecuritiesPledgedUnderLetterOfCreditFacilitiesAtFairValue
200000
CY2021Q3 us-gaap Security Owned And Pledged As Collateral Fair Value
SecurityOwnedAndPledgedAsCollateralFairValue
200000
CY2021Q3 dvax Payment To Holdings
PaymentToHoldings
500000
CY2021Q3 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
457200000
CY2021Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1409000
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
2145000
CY2021Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
265000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
402000
CY2021Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1674000
us-gaap Interest Expense Debt
InterestExpenseDebt
2547000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
108270000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13414000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
244372000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27001000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-28430000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
4401000
us-gaap Net Income Loss
NetIncomeLoss
-23066000
us-gaap Net Income Loss
NetIncomeLoss
-59773000
CY2021Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-367000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28430000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
4034000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23066000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-59773000
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-21245000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4200000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28430000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17211000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-23066000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-63973000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
116903000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109816000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114540000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
97589000
CY2021Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
CY2020Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
2157000
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
988000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116903000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
111973000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114540000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
98577000
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32362000
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15124000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32712000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15124000
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119787380
CY2019Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18525000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q3 dvax Number Of Common Stock Warrant Exercised
NumberOfCommonStockWarrantExercised
946150
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8505000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3562000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.96
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
890000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.10
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10264000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.37
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M29D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15032000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
9837000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
11.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y2M23D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
14656000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5668000
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
4102000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
15123000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.32
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y9M18D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8435000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
5376000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
9968000

Files In Submission

Name View Source Status
0000950170-21-003113-index-headers.html Edgar Link pending
0000950170-21-003113-index.html Edgar Link pending
0000950170-21-003113.txt Edgar Link pending
0000950170-21-003113-xbrl.zip Edgar Link pending
dvax-20210930.htm Edgar Link pending
dvax-20210930.xsd Edgar Link pending
dvax-20210930_cal.xml Edgar Link unprocessable
dvax-20210930_def.xml Edgar Link unprocessable
dvax-20210930_htm.xml Edgar Link completed
dvax-20210930_lab.xml Edgar Link unprocessable
dvax-20210930_pre.xml Edgar Link unprocessable
dvax-ex10_2.htm Edgar Link pending
dvax-ex10_3.htm Edgar Link pending
dvax-ex31_1.htm Edgar Link pending
dvax-ex31_2.htm Edgar Link pending
dvax-ex32_1.htm Edgar Link pending
dvax-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending